Medtronic, Philips to develop imaging-guided afib cryoablation system

A control room featuring Philips' Kodex-EPD system (Philips International B.V.)

Two of the world’s top 10 medtech companies have begun working together on a cryogenic therapy featuring an integrated, real-time guidance system for the treatment of atrial fibrillation.

Diagnostic imaging mainstay Philips will supply its Kodex-EPD dielectric vision and navigation platform—along with specialized, cryoablation-focused additions and clinical software—while Medtronic will provide its line of Arctic Front Advance catheters.

In addition, Medtronic will “facilitate the sales of products on behalf of Philips” under the collaboration, as they work on the paroxysmal atrial fibrillation treatment that aims to reduce the need for X-ray imaging. The integrated solution is expected to roll out to the U.S. and Europe by the end of the year.


Like this story? Subscribe to FierceBiotech!

Biopharma is a fast-growing world where big ideas come along every day. Our subscribers rely on FierceBiotech as their must-read source for the latest news, analysis and data in the world of biotech and pharma R&D. Sign up today to get biotech news and updates delivered to your inbox and read on the go.

RELATED: The top 10 medtech companies of 2024

“This integrated solution can guide physicians during the treatment of AF patients with ablation, as they can view detailed, CT-like 3D anatomy,” Philips EPD solutions business leader Marlou Janssen said in a statement.

“Today, this technology is simplifying navigation, and in the future it has potential for a wide range of applications, including addressing the key unmet need of real-time therapy assessment—one of the more significant limitations of the current standard of care,” Janssen said.

RELATED: To Philips, the future means more than just selling a better MRI machine

During a pulmonary vein isolation procedure, the real-time system will be used to confirm the position of Medtronic’s mapping catheter. Philips is working on balloon visualization capabilities, as well.

The Kodex system also includes heart-mapping capabilities that keep track of a patient’s movement during both cryo and heat-energy radiofrequency ablation procedures.

Suggested Articles

Avidity Biosciences is on a roll—after inking an R&D deal with Eli Lilly and hiring a new CEO, the company is reeling in $100 million.

What the NASH field needs, says Genfit CEO Pascal Prigent, is something like the Hb1Ac test for diabetes.

Dubbed “Project Nightingale,” the efforts were announced amid concerns and federal inquiries into the data’s safekeeping and patient consent for use.